eAppendix. Methods

Inclusion and exclusion criteria, informed consent
Inclusion criteria consisted of: age 6 years and older and a DSM-III-R, DSM-IV, or DSM-IV-TR diagnosis of Tourette syndrome (TS) (verified by the best estimate assessment, described in the text) in the proband. All participants were also required to have living parents for family-based genetic analyses, and parents were interviewed for corroborative history to supplement participant interviews regardless of participant age whenever possible. Exclusion criteria included tics caused by neurologic disorders other than TS and mental retardation (operationalized as an estimated IQ lower than 75 on a brief IQ scale, such as all or specific subscales of the Wechsler Intelligence Scale for Children-Revised 1 ). Pervasive developmental disorder (PDD) were also excluded during the first half of the study. However, due to time and resource limitations, we did not formally assess PDD in this sample. Only individuals with an established PDD diagnosis or with a suspected PDD based on medical record review were excluded; this exclusion criterion was removed from subsequent waves in part because it had not been operationalized.
Children ages 6 and up provided assent-parental permission was also obtained for all children under age 18. We decided to limit inclusion to age 6 years and older because of difficulties in obtaining reliable diagnostic information and blood for genetic testing from younger participants.
Diagnostic instruments, rater training and reliability, age of onset, and best-estimate process
Diagnostic instruments
The two primary diagnostic instruments used were the Structured Clinical Interview for DSM Disorders (SCID) 6 for adults and the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL) 7 for children and adolescents. A subset of adult participants ascertained very early in the study from one site (192 participants, 22 of whom were probands) had assessments using the SADS-LA, as this instrument was being used in an unrelated study and the researchers wished to avoid undue subject burden.
For children and adolescents, parents and children were interviewed using the K-SADS-PL jointly or separately, depending on the family's preference. The source of information for each diagnostic interview was not systematically recorded; however, in all cases, interviewers were instructed to make reasonable efforts to consider child or adolescent input when appropriate. For adult probands, parents were interviewed whenever possible to corroborate data.
Rater training and reliability
Interviewer training varied in structure between the sites, but in all cases involved didactic instruction, observation of the assessment by experienced interviewers, and subsequent direct observation by experienced interviewers until assessors achieved proficiency. In addition, interviewers were required to administer each diagnostic interview to a master clinician at their site to receive approval to conduct the interview independently. A refresher training occurred approximately halfway through the study to maintain reliability. Reliability between interviewers was not assessed in a systematic way other than at the time of the two trainings. Instead, the focus of our efforts with regard to reliability was at the level of the best estimates (see below). However, a representative from each clinical site was required to attend weekly/semi-monthly clinician conference calls where challenging diagnoses were discussed as well as questions/clarifications regarding diagnostic instruments. The coordinating site also conducted intermittent quality control checks of submitted data over the course of the study and provided feedback to clinical sites.
Age of onset
Using all available data, age of onset was defined retrospectively as the earliest time point in which the participant had clinically significant symptoms for the disorder in question. Previous research provides evidence that individuals tend to recall age of symptom onset later than when criteria were actually met 8 , suggesting that our ageof-onset data are perhaps even an underestimate of the true age at which comorbid disorders began. That is, due to recall bias, the exclusion of children younger than age 6 would likely bias the age of onset estimates towards later ages of onset
Best-estimate process
Inter-rater reliability was established for the best estimate diagnoses at the beginning of the study using a series of test cases. Reliability of diagnoses was maintained via weekly clinician calls between best estimators, led by Dr. Mathews. All participants, including probands and family members, were reviewed by the same committee. Clinicians from sites that performed the assessments generally did not conduct the best estimates for participants from that site. If best estimators disagreed and could not reach consensus, the case was best estimated by a third reviewer. If consensus could not be reached by the three reviewers, the diagnosis in question was coded as "unable to code" and was not included in the analysis. Difficult diagnostic issues of general relevance to all best estimators were brought to the best estimate committee for discussion.
Heritability analyses
The heritability of a trait, such as a psychiatric disorder, represents the fraction of the total phenotypic variance accounted for by the additive genetic variance. All analyses included sex, age, and the sex-by-age interaction as covariates. TS and chronic motor or vocal tic disorder (CMVTD) were combined for these analyses. First, we estimated the univariate heritability of TS/CMVTD and comorbid disorders. Next, we estimated the genetic and environmental correlations (RhoG and RhoE, respectively) between TS/CMVTD and each of the comorbid disorders. To examine the independent effects of TS from OCD and ADHD, we added OCD and ADHD separately (and together if the RhoG remained significant at P < .05) as covariates in these bivariate analyses. Next, to directly examine the independent effects of comorbid OCD and ADHD on genetic correlation between TS/CMVTD and other comorbid disorders, we tested the bivariate relationship between OCD and ADHD with the other comorbid disorders for those disorders that showed a significant RhoG with TS/CMVTD. If those bivariate relationships yielded a significant RhoG, we then repeated the analyses controlling for TS/CMVTD and the other disorder, either OCD or ADHD (separately, and then together if the RhoG was significant when controlling for either OCD or ADHD separately). This algorithm is depicted in Supplemental Figure S1 . This sequence of testing allowed us to examine the independent effects of OCD and ADHD in the genetic correlation between TS/CMVTD and other comorbid disorders. It should be noted, however, that because the sample contains only two generation families and no monozygotic or dizygotic twins, the RhoG cannot parse the contribution of heritability from common environment. Therefore, RhoG is more accurately the "familial" component; however, we have chosen to use the term "genetic correlation" in line with the common usage as employed by the authors of SOLAR. In a series of logistic regression models, lifetime diagnosis of each comorbid disorder was defined as the dependent variable, and proband status (yes/no) was the independent variable. In a second series of models, age was added as an independent variable. * p < .05, ** p < .01, p < . To determine the association between TS and comorbid disorders, independent of ADHD and OCD, a series of univariate and multivariate generalized estimating equations were modeled with each comorbid disorder as the outcome and TS, ADHD, and/or OCD as the predictor variables. Both TS-affected and TS-unaffected individuals were included. All models included age at interview and sex as covariates. .31 n/a n/a n/a n/a n/a n/a n/a n/a Substance use .22 (.32) .48 -.17 (.26) .52 n/a n/a n/a n/a n/a n/a n/a n/a Elimination 1.0 (n/a) .13 -.22 (1.0) .43 n/a n/a n/a n/a n/a n/a n/a n/a Genetic and environmental correlation (RhoG and RhoE, respectively) between TS/CMVTD and groups of comorbid disorders were estimated; where RhoG was significant, ADHD and OCD were added separately as covariates to assess the independent association between TS/CMVTD and the given cormorbid disorders. a All analyses include sex, age, and sex-by-age as covariates. ADHD, attention-deficit/hyperactivity disorder; OCD, obsessive-compulsive disorder; TS/CMVTD, Tourette syndrome/chronic motor and vocal tic disorder
